PNC FINANCIAL SERVICES GROUP, INC.

Position in PMVP — PMV Pharmaceuticals, Inc.

CIK 713676 Pittsburgh, PA

Position in PMVP

as of Mar 31, 2026 · filed May 8, 2026 Compact

Position Value

$84,680

-$6,833 QoQ

Shares Held

68,292

-6.7% QoQ

Ownership

0.128%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

PNC FINANCIAL SERVICES GROUP, INC. holds $99,747,802 across 265 Biotechnology names. PMVP ranks #76 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	71,942	$32,124,978
2	REGN	Regeneron Pharmaceuticals, Inc.	18,226	$14,082,131
3	TECH	BIO-TECHNE Corp	93,722	$4,897,909
4	ALNY	Alnylam Pharmaceuticals, Inc.	12,322	$4,076,976
5	MRNA	Moderna, Inc.	69,883	$3,550,054
6	INCY	Incyte Corp	33,976	$3,197,817
7	DNTH	Dianthus Therapeutics, Inc. /DE/	37,360	$3,135,250
8	ARGX	Argenx SE	3,796	$2,772,027

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$84,680	68,292	-6.7%	Shares	Defined	2026-05-08
2025-12-31	$91,513	73,211	+3.1%	Shares	Defined	2026-02-06
2025-09-30	$99,408	71,006	+16.7%	Shares	Defined	2025-11-07
2025-06-30	$64,468	60,820	-2.1%	Shares	Defined	2025-08-08
2025-03-31	$67,725	62,134	-10.1%	Shares	Defined	2025-05-09
2024-12-31	$104,359	69,113	-0.2%	Shares	Defined	2025-02-07
2024-09-30	$103,150	69,229	+60.1%	Shares	Defined	2024-11-08
2024-06-30	$70,056	43,246	+166230.8%	Shares	Defined	2024-08-09
2024-03-31	$44	26	0.0%	Shares	Defined	2024-05-10
2023-12-31	$80	26	-97.4%	Shares	Defined	2024-03-22
2023-09-30	$6,058	987	0.0%	Shares	Defined	2023-11-13
2023-06-30	$6,178	987	0.0%	Shares	Defined	2023-08-11
2023-03-31	$4,706	987	—	Shares	Defined	2023-05-15
No filing history on record for this holder in this stock.